Daniele Marrelli
Overview
Explore the profile of Daniele Marrelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
232
Citations
3834
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bencivenga M, Ministrini S, Morgagni P, Mura G, Marrelli D, Milandri C, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201597
Background: Interest in the field of metastatic gastric cancer has grown in recent years, and the identification of oligometastatic patients plays a critical role as it consents to their inclusion...
12.
Calomino N, Poto G, Carbone L, Bagnacci G, Piccioni S, Andreucci E, et al.
Ann Ital Chir
. 2023 Dec;
94:518-522.
PMID: 38051513
Background: Gastro-entero-pancreatic neuroendocrine tumors are gradually seeing their incidence increase, probably due to their low-rate mortality. Surgery and subsequent medical therapy through octeotride and somatostatin analogues is the recommended approach...
13.
Ministrini S, Bencivenga M, Filippini F, Mura G, Milandri C, Mazzei M, et al.
Eur J Surg Oncol
. 2023 Nov;
50(1):107275.
PMID: 37995604
Introduction: The Italian Research Group for Gastric Cancer developed a prospective database about stage IV gastric cancer, to evaluate how a pragmatic attitude impacts the management of these patients. Materials...
14.
Fusario D, Neri A, Carbone L, Resca L, Marano L, Grassi G, et al.
World J Surg
. 2023 Sep;
47(11):2945-2946.
PMID: 37658130
No abstract available.
15.
Sammartino P, De Manzoni G, Marano L, Marrelli D, Biacchi D, Sommariva A, et al.
Cancers (Basel)
. 2023 Jun;
15(12).
PMID: 37370747
Gastric cancer (GC) continues to be one of the leading types of malignancies worldwide, despite an ongoing decrease in incidence. It is the fifth most frequent type of cancer in...
16.
Casella F, Bencivenga M, Brancato G, Torroni L, Ridolfi C, Puccio C, et al.
Ann Surg Oncol
. 2023 Jun;
30(9):5733-5742.
PMID: 37270440
Background: This study evaluated the efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with systemic chemotherapy as a bidirectional approach for gastric cancer (GC) patients with synchronous peritoneal metastases (SPM). Methods:...
17.
Marano L, Verre L, Carbone L, Poto G, Fusario D, Venezia D, et al.
J Clin Med
. 2023 Apr;
12(7).
PMID: 37048791
Gastric cancer is ranked as the fifth most frequently diagnosed type of cancer. Complete resection with adequate lymphadenectomy represents the goal of treatment with curative intent. Quality assurance is a...
18.
Fusario D, Neri A, Carbone L, Resca L, Marano L, Gassi G, et al.
World J Surg
. 2023 Mar;
47(7):1713-1720.
PMID: 36947203
Background: Identification of reliable risk-stratification tools is critical for surgical decision making, particularly in frail and elderly. The aim of the study is to validate the Emergency Surgery Frailty Index...
19.
Kusamura S, Baratti D, De Simone M, Pasqual E, Ansaloni L, Marrelli D, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765620
Diffuse malignant peritoneal mesothelioma (DMPM) is a rare form of mesothelioma that carries a very poor prognosis. The 5-year overall survival is about 20% (±5.9). Survival is optimal for patients...
20.
Ghirardi V, Fagotti A, Ansaloni L, Valle M, Roviello F, Sorrentino L, et al.
Cancers (Basel)
. 2023 Jan;
15(2).
PMID: 36672356
Over two thirds of ovarian cancer patients present with advanced stage disease at the time of diagnosis. In this scenario, standard treatment includes a combination of cytoreductive surgery and carboplatinum-paclitaxel-based...